Race for coronavirus treatment - As the global race continues to try and find a treatment for coronavirus the UK biotech firm Synairgen is reportedly planning to trial its experimental lung drug on Covid-19 patients.
The company received the green light from UK regulators to conduct a trial of its lead drug SNG001 at NHS trusts across the country.
The inhaled drug has been in development as a treatment for chronic-obstructive pulmonary disorder (COPD), a severe lung disease, but this has been paused to conduct testing on 100 patients who have been diagnosed with Covid-19.
It was identified in a WHO analysis of potential treatments against the coronavirus. Patients can self-administer it, through a small hand-held battery-operated nebulizer.
The trial is due to start next week.
The French government has announced a prohibition on mobile phone use in six prisons
Read More
A sharp blast of Arctic air is set to hit the Côte d’Azur this weekend, with temperatures dipping to –4°C in parts of the Alpes-Maritimes and the Var....
Read More
Two men and a woman from Beaulieu-sur-Mer have been appearing in court today as part of a judicial investigation into suspected money laundering and t...
Read More
Monaco celebrated its National Day on Wednesday with a blend of religious tradition, military honours and public festivities. The day began with a Te ...
Read More
It’s Monaco’s National Day, with several ceremonies and celebrations happening throughout the Principality today. ...
Read More
